3D Biology™ Technology
For Research Use Only. Not for use in diagnostic procedures.
Helping Your Research
3D Biology is the ability to analyze combinations of RNA and protein simultaneously in a single experiment, from a single sample.
At NanoString, we are pioneering 3D Biology to accelerate your research and maximize the amount of information that can be generated from a single sample. Based on NanoString’s digital barcode technology and designed for flexibility, NanoString’s 3D Biology™ Technology and the nCounter® Vantage 3D™ portfolio of assays, provides a deeper view of cancer and immune biology and can be mixed and matched to answer a wide variety of biological questions.
- Quantify both RNA and protein in a single assay to use less precious material and uncover novel insights
- Simplify your workflow by comparing gene and protein expression for up to 800 targets in a single view
- Eliminate the potential bias inherent in merging data from different platforms
NanoString protein analysis leverages antibodies that are barcoded with unique synthetic DNA oligonucleotides for detection of proteins of interest. The DNA oligonucleotide is recognized by a unique reporter probe that contains a fluorescent barcode. Following sample preparation, RNA and protein can all be detected on the nCounter® platform yielding counts of mRNA and protein abundance.
Our Vantage 3D Assays are powered by 3D Biology technology and provide solutions across an expanding range of research areas. For more information download our Vantage 3D Brochure.
3D Flow™ Analysis: Seamlessly integrate standard flow cytometry cell sorting with downstream nCounter analysis to interrogate up to 30 proteins and 770 immune-related RNA simultaneously. View details here.
PDX Profiling: Simple and comprehensive profiling to assure that your PDX models are of consistent high quality and that you gain a deeper understanding of the molecular determinants of therapeutic response. View details here.
In the Lab
Spatially resolved transcriptomics and its applications in cancer
Spatially resolved transcriptomics (SRT) offers the promise of understanding cells and their modes of dysfunction in the context of intact tissues. Technologies for SRT have advanced rapidly with a large number being published in recent years.
Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors
In recent years, cancer immunotherapy experienced remarkable developments and it is nowadays considered a promising therapeutic frontier against many types of cancer, especially hematological malignancies. However, in most types of solid tumors, immunotherapy efficacy is modest, partly because of the limited accessibility of lymphocytes to the tumor core.
A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer.
Providing effective personalized immunotherapy for triple negative breast cancer (TNBC) patients requires a detailed understanding of the composition of the tumor microenvironment. Both the tumor cell and non-tumor components of TNBC can exhibit tremendous heterogeneity in individual patients and change over time.